• High-dose pitavastatin benefits Japanese population with CAD

    11 monthes ago - By Healio

    ANAHEIM, Calif. - High-dose pitavastatin, compared with a low dose, significantly reduced CV events and was well-tolerated in Japanese adults with stable CAD enrolled in the REAL-CAD study.
    The prospective, randomized, open-label trial included 13,054 patients who received pitavastatin 1 mg per day for an initial run-in period of at least 1 month, followed by random assignment to the continued daily 1-mg dose or a 4-mg dose. Median follow-up duration was 3.9 years in both groups.
    High-dose pitavastatin significantly reduced the primary endpoint, a
    Read more ...